×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
ARTL – artelo biosciences, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
ARTL
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
11/18
08:35 am
artl
Artelo Biosciences to Present Key Data on Three Development Programs at the 7th Cannabinoid Drug Development Summit [Yahoo! Finance]
High
Report
Artelo Biosciences to Present Key Data on Three Development Programs at the 7th Cannabinoid Drug Development Summit [Yahoo! Finance]
11/18
08:30 am
artl
Artelo Biosciences to Present Key Data on Three Development Programs at the 7th Cannabinoid Drug Development Summit
High
Report
Artelo Biosciences to Present Key Data on Three Development Programs at the 7th Cannabinoid Drug Development Summit
11/13
08:30 am
artl
Artelo Biosciences Announces Promising New Data on Novel Non-Opioid Treatment Approach for Osteoarthritis Pain at the 13th Annual Musculoskeletal Repair and Regeneration Symposium
High
Report
Artelo Biosciences Announces Promising New Data on Novel Non-Opioid Treatment Approach for Osteoarthritis Pain at the 13th Annual Musculoskeletal Repair and Regeneration Symposium
11/13
08:05 am
artl
Artelo Biosciences, Inc. (NASDAQ: ARTL) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $5.00 price target on the stock.
Medium
Report
Artelo Biosciences, Inc. (NASDAQ: ARTL) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $5.00 price target on the stock.
11/12
08:00 am
artl
Artelo Biosciences Reports Third Quarter 2024 Financial Results and Provides Business Update
Low
Report
Artelo Biosciences Reports Third Quarter 2024 Financial Results and Provides Business Update
11/5
08:30 am
artl
Artelo Biosciences Announces Acceptance of ART26.12 into the National Institutes of Health’s “Preclinical Screening Platform for Pain” Program
High
Report
Artelo Biosciences Announces Acceptance of ART26.12 into the National Institutes of Health’s “Preclinical Screening Platform for Pain” Program
10/9
09:00 am
artl
Artelo Biosciences CEO to Participate in Fireside Chat at the Maxim Group Virtual Healthcare Summit on October 16th
Low
Report
Artelo Biosciences CEO to Participate in Fireside Chat at the Maxim Group Virtual Healthcare Summit on October 16th
10/3
05:53 am
artl
Artelo Biosciences, Inc. (NASDAQ: ARTL) was upgraded by analysts at EF Hutton Acquisition Co. I to a "strong-buy" rating.
Low
Report
Artelo Biosciences, Inc. (NASDAQ: ARTL) was upgraded by analysts at EF Hutton Acquisition Co. I to a "strong-buy" rating.
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
11/12
09:35 am
artl
Form 10-Q ARTELO BIOSCIENCES, INC. For: Sep 30
Medium
Report
Form 10-Q ARTELO BIOSCIENCES, INC. For: Sep 30
11/8
04:34 pm
artl
Form DEF 14A ARTELO BIOSCIENCES, INC. For: Dec 19
Low
Report
Form DEF 14A ARTELO BIOSCIENCES, INC. For: Dec 19
11/8
04:33 pm
artl
Form DEFA14A ARTELO BIOSCIENCES, INC.
Low
Report
Form DEFA14A ARTELO BIOSCIENCES, INC.
11/8
04:31 pm
artl
Form ARS ARTELO BIOSCIENCES, INC. For: Dec 31
Low
Report
Form ARS ARTELO BIOSCIENCES, INC. For: Dec 31
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
6/21
Form EFFECT ARTELO BIOSCIENCES, INC.
284.3%
4/14 Artelo Biosciences Reports Second Quarter Fiscal Year 2020 Financial Results and Provides Business Update 31.4%
2/3 Artelo Biosciences Announces NCI Grant of $4.2 Million to Stony Brook University to Advance FABP5 Inhibitor Cancer Program 23.3%
7/9 Artelo Biosciences (NASDAQ: ARTL) is now covered by analysts at Maxim Group. They set a "buy" rating on the stock. 20.1%
6/20 Form S-1/A ARTELO BIOSCIENCES, INC. 15.2%
11/1 Form 4 ARTELO BIOSCIENCES, INC. For: Oct 30 Filed by: Gorgas Gregory D. 9.2%
3/23 Artelo Biosciences to Present at the Spring Investor Summit on March 25th 8.8%
9/11 Artelo Biosciences to Present at the Fall Investor Summit in New York City on September 17th 7.3%
8/30 Form 4 ARTELO BIOSCIENCES, INC. For: Aug 29 Filed by: MATSUI CONNIE 7.2%
6/25 Form 8-K ARTELO BIOSCIENCES, INC. For: Jun 21 6.5%
4/14 Artelo Biosciences Reports Second Quarter Fiscal Year 2020 Financial Results and Provides Business Update 31.4%
2/3 Artelo Biosciences Announces NCI Grant of $4.2 Million to Stony Brook University to Advance FABP5 Inhibitor Cancer Program 23.3%
7/9 Artelo Biosciences (NASDAQ: ARTL) is now covered by analysts at Maxim Group. They set a "buy" rating on the stock. 20.1%
6/20 Form S-1/A ARTELO BIOSCIENCES, INC. 15.2%
11/1 Form 4 ARTELO BIOSCIENCES, INC. For: Oct 30 Filed by: Gorgas Gregory D. 9.2%
3/23 Artelo Biosciences to Present at the Spring Investor Summit on March 25th 8.8%
9/11 Artelo Biosciences to Present at the Fall Investor Summit in New York City on September 17th 7.3%
8/30 Form 4 ARTELO BIOSCIENCES, INC. For: Aug 29 Filed by: MATSUI CONNIE 7.2%
6/25 Form 8-K ARTELO BIOSCIENCES, INC. For: Jun 21 6.5%
TOP News Decliners
10/17
Form 4 ARTELO BIOSCIENCES, INC. For: Oct 15 Filed by: Gorgas Gregory D.
-21.0%
3/11 Form 8-K ARTELO BIOSCIENCES, INC. For: Mar 06 -15.9%
11/25 Artelo Biosciences Reports Fourth Quarter and Fiscal Year 2019 Financial Results and Provides Business Update -15.9%
6/10 Form S-1/A ARTELO BIOSCIENCES, INC. -15.4%
4/15 Form 8-K ARTELO BIOSCIENCES, INC. For: Apr 13 -14.0%
1/15 Form S-3 ARTELO BIOSCIENCES, INC. -13.6%
2/4 Form EFFECT ARTELO BIOSCIENCES, INC. -12.0%
2/14 Form SC 13G ARTELO BIOSCIENCES, INC. Filed by: Moss David J -10.6%
10/30 Form S-3 ARTELO BIOSCIENCES, INC. -9.1%
2/3 Artelo's [MarketWatch] -8.9%
3/11 Form 8-K ARTELO BIOSCIENCES, INC. For: Mar 06 -15.9%
11/25 Artelo Biosciences Reports Fourth Quarter and Fiscal Year 2019 Financial Results and Provides Business Update -15.9%
6/10 Form S-1/A ARTELO BIOSCIENCES, INC. -15.4%
4/15 Form 8-K ARTELO BIOSCIENCES, INC. For: Apr 13 -14.0%
1/15 Form S-3 ARTELO BIOSCIENCES, INC. -13.6%
2/4 Form EFFECT ARTELO BIOSCIENCES, INC. -12.0%
2/14 Form SC 13G ARTELO BIOSCIENCES, INC. Filed by: Moss David J -10.6%
10/30 Form S-3 ARTELO BIOSCIENCES, INC. -9.1%
2/3 Artelo's [MarketWatch] -8.9%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: